Archive for May 2018
Product Briefs – SeptiCyte LAB
Immunexpress, Inc. published in the American Journal of Respiratory and Clinical Care Medicine the design and results of clinical trials validating SeptiCyte™ LAB in the discrimination of sepsis from non-infectious systemic inflammatory response syndrome (SIRS) in the Intensive Care Unit (ICU) of hospitals.
Read MoreMolecular Laboratory Test Can Discriminate Sepsis From Noninfectious SIRS
Design and results of clinical trials that led to FDA clearance of SeptiCyte™ LAB published in the American Journal of Respiratory and Clinical Care Medicine.
Read MoreAppointments and advancements – Rolland Carlson, Tanja Dowe, Katleen Verleysen
Immunexpress strengthens Board of Directors with key appointments.
Read MorePeople in the News: Rolland Carlson, Tanja Dowe, Katleen Verleysen
Accomplished industry leaders join recently appointed CEO, Dr. Rolland Carlson, to expand on the comprehensive experience of the Board.
Read MoreSeptiCyte™ LAB Differentiates Sepsis from SIRS in the ICU
Design and results of clinical trials that led to FDA clearance of SeptiCyte™ LAB published in the American Journal of Respiratory and Clinical Care Medicine SEATTLE, May 9, 2018 /PRNewswire/ — Immunexpress, Inc. today announced the publication in the American Journal of Respiratory and Clinical Care Medicine of the design and results of clinical trials validating SeptiCyte™ LAB in the…
Read MoreImmunexpress Strengthens Board of Directors with Key Appointments
Accomplished Industry Leaders Join Recently Appointed CEO, Dr. Rolland Carlson, to Expand on the Comprehensive Experience of the Board SEATTLE, May 15, 2018 /PRNewswire/ — Immunexpress, Inc. today announced the appointment of three new members to its Board of Directors. Rolland Carlson, PhD, Tanja Dowe and Katleen Verleysen, PhD, have joined the company’s board, while Bea Arnold, PhD, has stepped down from the board after…
Read More